Antiepileptic drugs for chronic neuropathic pain

Although the efficacy of the first-generation epigenetic drugs (epi-drugs) in solid tumor management has been disappointing, there is an increasing body of evidence showing

After developing such a model, based on a bivariate discrete time hazard model with shared frailty, the conclusion from the empirical findings is that the

Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain

Com- parison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Davidoff G, Guarracini M, Roth E

48 Practice differences in the management of moderate-to-severe (chronic) pain are illustrated by studies that compared the post-operative treatment of pain (after

Furthermore, Poisson regression was used to investi- gate whether poor mental health stratified by chronic pain in transit (baseline) predicted chronic pain in the early

Ketamine is a commonly used anaesthetic agent, and in subanaesthetic doses is also given as an adjuvant to opioids for the treatment of cancer pain, particularly when opioids

Ketamine is the most studied NMDA receptor antagonist in clinical pain trials, and is commonly used for the treatment of refractory cancer pain, and as an opioid-sparing drug in